HomeCompareHBPCF vs EPRT

HBPCF vs EPRT: Dividend Comparison 2026

HBPCF yields 115.61% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HBPCF wins by $7.17M in total portfolio value
10 years
HBPCF
HBPCF
● Live price
115.61%
Share price
$1.73
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.23M
Annual income
$2,676,132.53
Full HBPCF calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — HBPCF vs EPRT

📍 HBPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHBPCFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HBPCF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HBPCF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HBPCF
Annual income on $10K today (after 15% tax)
$9,826.59/yr
After 10yr DRIP, annual income (after tax)
$2,274,712.65/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, HBPCF beats the other by $2,263,517.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HBPCF + EPRT for your $10,000?

HBPCF: 50%EPRT: 50%
100% EPRT50/50100% HBPCF
Portfolio after 10yr
$3.65M
Annual income
$1,344,651.69/yr
Blended yield
36.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

HBPCF
No analyst data
Altman Z
17.7
Piotroski
1/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HBPCF buys
0
EPRT buys
0
No recent congressional trades found for HBPCF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHBPCFEPRT
Forward yield115.61%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$7.23M$64.3K
Annual income after 10y$2,676,132.53$13,170.85
Total dividends collected$6.55M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HBPCF vs EPRT ($10,000, DRIP)

YearHBPCF PortfolioHBPCF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$22,261$11,560.69$11,212$512.01+$11.0KHBPCF
2$47,870$24,051.31$12,689$692.09+$35.2KHBPCF
3$99,558$48,337.27$14,521$944.30+$85.0KHBPCF
4$200,481$93,953.00$16,841$1,302.88+$183.6KHBPCF
5$391,330$176,815.76$19,841$1,821.64+$371.5KHBPCF
6$741,281$322,558.19$23,818$2,587.47+$717.5KHBPCF
7$1,364,208$571,036.96$29,230$3,744.65+$1.33MHBPCF
8$2,441,853$982,150.40$36,816$5,540.38+$2.41MHBPCF
9$4,255,766$1,642,983.32$47,806$8,413.17+$4.21MHBPCF
10$7,229,802$2,676,132.53$64,324$13,170.85+$7.17MHBPCF

HBPCF vs EPRT: Complete Analysis 2026

HBPCFStock

Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Full HBPCF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this HBPCF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HBPCF vs SCHDHBPCF vs JEPIHBPCF vs OHBPCF vs KOHBPCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.